Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia

Proteomics

Volumn 10, Issue 23, 2010, Pages 4270-4280

  Gonzales, Denise A ^a   Torre, Carlos De ^a   Wang, Honghui ^a   Devor, Christopher B ^b   Munson, Peter J ^c   Ying, Sai Xia ^c   Kern, Steven J ^a   Petraitiene, Ruta ^b,d   Levens, David L ^b   Walsh, Thomas J ^b   Suffredini, Anthony F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

Animal proteomics; Aspergillus fumigatus; Neutropenia; Pneumonia; Pseudomonas aeruginosa

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; HAPTOGLOBIN; PLASMA PROTEIN; PREALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HOST RESISTANCE; LUNG ASPERGILLOSIS; LUNG LAVAGE; NEUTROPENIC ENTEROCOLITIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PSEUDOMONAS PNEUMONIA; RANDOM FOREST; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; ASPERGILLUS FUMIGATUS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CLUSTER ANALYSIS; FEMALE; INVASIVE PULMONARY ASPERGILLOSIS; PNEUMONIA, BACTERIAL; PROTEOME; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ORYCTOLAGUS CUNICULUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 78649658120     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900768     Document Type: Article

References (47)

1. Petricoin, E., Wulfkuhle, J., Espina, V., Liotta, L. A., Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J. Proteome Res. 2004, 3, 209-217.
2. Liotta, L. A., Ferrari, M., Petricoin, E., Clinical proteomics: written in blood. Nature 2003, 425, 905.
3. Whelan, L. C., Power, K. A., McDowell, D. T., Kennedy, J., Gallagher, W. M., Applications of SELDI-MS technology in oncology. J. Cell Mol. Med. 2008, 12, 1535-1547.
4. Petricoin, E. F., Liotta, L. A., SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 2004, 15, 24-30.
5. Liu, X. P., Shen, J., Li, Z. F., Yan, L., Gu, J., A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Cancer Invest. 2006, 24, 747-753.
6. Petricoin, E. F., Belluco, C., Araujo, R. P., Liotta, L. A., The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 2006, 6, 961-967.
7. Bradford, T. J., Tomlins, S. A., Wang, X., Chinnaiyan, A. M., Molecular markers of prostate cancer. Urol. Oncol. 2006, 24, 538-551.
8. National Research Council Committee on the Care and Use of Laboratory Animals, Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources Commission on Life Sciences, National Academy Press, Washington, DC 1996.
9. Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T. et al., Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob. Agents Chemother. 2002, 46, 12-23.
10. Francis, P., Lee, J. W., Hoffman, A., Peter, J. et al., Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J. Infect. Dis. 1994, 169, 356-368.
11. Petraitis, V., Petraitiene, R., Solomon, J., Kelaher, A. M. et al., Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 2006, 50, 1510-1517.
12. Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T. et al., Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob. Agents Chemother. 2001, 45, 857-869.
13. Walsh, T. J., McEntee, C., Dixon, D. M., Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans. J. Clin. Microbiol. 1987, 25, 931-932.
14. de Torre, C., Ying, S. X., Munson, P. J., Meduri, G. U., Suffredini, A. F., Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 2006, 6, 3949-3957.
15. Ihaka, R., Gentleman, R., R: A language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5, 299-314.
16. Hutchens, T. W., Yip, T.-T., New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 1993, 7, 576-580.
17. Qu, Y., Adam, B. L., Yasui, Y., Ward, M. D. et al., Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 2002, 48, 1835-1843.
18. Paweletz, C. P., Trock, B., Pennanen, M., Tsangaris, T. et al., Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers 2001, 17, 301-307.
19. Mor, G., Visintin, I., Lai, Y., Zhao, H. et al., Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. USA 2005, 102, 7677-7682.
20. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., Chan, D. W., Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48, 1296-1304.
21. Srinivasan, R., Daniels, J., Fusaro, V., Lundqvist, A. et al., Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp. Hematol. 2006, 34, 796-801.
22. Papadopoulos, M. C., Abel, P. M., Agranoff, D., Stich, A. et al., A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 2004, 363, 1358-1363.
23. Pang, R. T., Poon, T. C., Chan, K. C., Lee, N. L. et al., Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin. Chem. 2006, 52, 421-429.
24. Buhimschi, C. S., Bhandari, V., Hamar, B. D., Bahtiyar, M. O. et al., Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 2007, 4, e18.
25. Agranoff, D., Fernandez-Reyes, D., Papadopoulos, M. C., Rojas, S. A. et al., Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368, 1012-1021.
26. Kniemeyer, O., Lessing, F., Brakhage, A. A., Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus. Med. Mycol. 2009, 47, S248-S254.
27. Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., Wright, S. D., Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 1994, 180, 1025-1035.
28. Grunfeld, C., Marshall, M., Shigenaga, J. K., Moser, A. H. et al., Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 1999, 40, 245-252.
29. Ma, J., Liao, X. L., Lou, B., Wu, M. P., Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim. Biophys. Sin. (Shanghai) 2004, 36, 419-424.
30. Fukuchi, Y., Kumagai, T., Ebina, K., Yokota, K., Apolipoprotein B inhibits the hemolytic activity of asp-hemolysin from Aspergillus fumigatus. Biol. Pharm. Bull. 1996, 19, 547-550.
31. Barter, P. J., Puranik, R., Rye, K. A., New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease. Curr. Cardiol. Rep. 2007, 9, 493-498.
32. Carpintero, R., Pineiro, M., Andres, M., Iturralde, M. et al., The concentration of apolipoprotein A-I decreases during experimentally induced acute-phase processes in pigs. Infect. Immun. 2005, 73, 3184-3187.
33. Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G. et al., Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 1996, 184, 1601-1608.
34. Rementeria, A., Lopez-Molina, N., Ludwig, A., Vivanco, A. B. et al., Genes and molecules involved in Aspergillus fumigatus virulence. Rev. Iberoam. Micol. 2005, 22, 1-23.
35. Eaton, J. W., Brandt, P., Mahoney, J. R., Lee, J. T., Jr., Haptoglobin: a natural bacteriostat. Science 1982, 215, 691-693.
36. Yang, F., Haile, D. J., Coalson, J. J., Ghio, A. J., Haptoglobin in lung defence. Redox Rep. 2001, 6, 372-374.
37. Arredouani, M., Matthys, P., Kasran, A., Baumann, H., Ceuppen, J. L., Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies. Redox Rep. 2001, 6, 369-371.
38. Zarember, K. A., Cruz, A. R., Huang, C. Y., Gallin, J. I., Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob. Agents Chemother. 2009, 53, 2654-2656.
39. Baseler, M. W., Burrell, R., Acute-phase reactants in experimental inhalation lung disease. Proc. Soc. Exp. Biol. Med. 1981, 168, 49-55.
40. Richardson, M. D., Shankland, G. S., Gray, C. A., Opsonizing activity of C-reactive protein in phagocytosis of Aspergillus fumigatus conidia by human neutrophils. Mycoses 1991, 34, 141-143.
41. Devaraj, S., Singh, U., Jialal, I., The evolving role of C-reactive protein in atherothrombosis. Clin. Chem. 2009, 55, 229-238.
42. Woollard, K. J., Phillips, D. C., Griffiths, H. R., Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin. Exp. Immunol. 2002, 130, 256-262.
43. Sainz, J., Perez, E., Gomez-Lopera, S., Jurado, M., IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J. Clin. Immunol. 2008, 28, 473-485.
44. Verdaguer, V., Walsh, T. J., Hope, W., Cortez, K. J., Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Exp. Rev. Mol. Diagn. 2007, 7, 21-32.
45. Buchheidt, D., Baust, C., Skladny, H., Ritter, J. et al., Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin. Infect. Dis. 2001, 33, 428-435.
46. Kami, M., Fukui, T., Ogawa, S., Kazuyama, Y. et al., Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin. Infect. Dis. 2001, 33, 1504-1512.
47. Anderson, N. L., The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol. Cell. Proteomics 2005, 4, 1441-1444.